Tag: stem cell stocks
Q4 Update: TFN Complete Guide to Stem Cell Stocks under $10
Published on September 25, 2009
by Tara Useller – TodaysFinancialNews.com
Baltimore — (TFN): With four major international stem cell conferences meeting this week – as well as 16 more scheduled before the end of the year; now is a good time to update our list of stem cell researchers and related biotech companies.
News of [...]
Set wealth protection stop-losses for ASTM, CRIS, and SGMO
Published on August 10, 2009
If you purchased each of the three stocks we recommended in "Today’s top 3 stem cell stocks under $6" on the day we issued the report, you’re up 40%, 22% and 43%, respectively. Let’s set a stop-loss to protect those gains.
by Laura Cadden, TodaysFinancialNews.com
Baltimore (TFN): On May 11, we issued the TFN Special [...]
The TFN Complete Guide to Biotech Penny Stocks
Published on July 24, 2009
In the course of our research to find the best biotech penny stocks, we compiled a list of all viable companies trading for less than $5 on U.S. exchanges. We appreciate that many of our TFN readers like to do their own analysis and hope this will prove a useful tool…
by The TFN Team
The following [...]
25 winning stock recommendations in 2009—for “cumulative gains” of 476%!
Published on May 21, 2009
Stem cell stocks, oil stocks, penny stocks, biotech stocks… in the market mess of 2009, one financial advisory has already closed out 25 recommendations with double-digit gains… or better!
These 3 biotechs could bring you gains of 422% in just 6 months
Published on March 23, 2009
The next generation in revolutionary biotechs has arrived. (And they may be the only way to make money in this market!)
Each one of these 3 breakout stocks could realistically bring you gains of 128%, 185%, or even 422% in the next 6 months!
Jan. 23, 2009 was a historic date in [...]
Strategic Options Update: Looking at insurance stocks next week!
Published on March 13, 2009
After a bullish week on Wall Street, we think that insurance companies may be in for a boost next week.
by J. Christoph Amberger
Baltimore—TFN: We have reached the end of a very positive week for Wall Street. All it took was a little good news from the banking industry and the government’s promise to make some well-needed [...]
Strategic Options Update: Up 325%… and counting!
Published on March 11, 2009
Goodness gracious… last week’s options pick is heading straight out of the ballpark, clocking in at 325% this morning. It’s going so well, options expert Andrew Snyder is considering upping our profit target to 1,500%…
by J. Christoph Amberger
Baltimore—TFN: Forget about spring training… we’re hitting grand slams right here in Baltimore! If you’re not in on [...]
An up and coming biotech: Human Genome Sciences Inc. (HGSI)
Published on February 4, 2009
A lucrative government contract is just one of the things this small cap has going for it.
Stem Cell Penny Stock: Cord Blood is up 57% for the day!
Published on January 29, 2009
Thanks to the perception that Congress has opened the free-for-all at the stimulus trough, some highly speculative stem cell plays are soaring. One of them is Monday’s TFN Editor’s Pic, Cord Blood America (OTC:CBAI).
by J. Christoph Amberger
When you’re expecting your first child, you buy into all kinds of nonsense. Back in the day (I’m dating [...]
Geron Corporation (GERN) up 36% on news of FDA go-ahead
Published on January 24, 2009
One of our top biotech picks, Geron Corporation, is basking in the glory of FDA clearance to begin trials of its human embryonic stem cell-based therapy for patients with acute spinal cord injury.
By Laura Cadden, TodaysFinancialNews.com
Baltimore (TFN): This summer, new sufferers of acute spinal cord injuries may have a greater chance for recovery than their [...]
Four biotechs set to soar
Published on January 12, 2009
Each of these ground-floor stem cell stocks can help you multiply every dollar invested as much as three, four, maybe even ten times!
Reap the gains on TFN’s stem cell stock recommendations!
Published on January 6, 2009
Each of our recommended 3 hottest stem cell stocks has hit at least 20% gains from our original buy price. Enjoy!
By Laura Cadden, TodaysFinancialNews.com
Baltimore — (TFN): Over a month ago, we told you about the 3 Hottest Stem Cell Stocks under $5.
Our report read, “Even a moderate investment may pay off handsomely if the reinstatement [...]
Happy Thanksgiving… and a glimpse of things to come
Published on November 26, 2008
As America enters the holiday season, we take a look ahead: What can we expect for the last weeks of 2008… and beyond!
The 3 Hottest Stem Cell Stocks Under $5
Published on November 26, 2008
Each of these ground-floor stem cell stocks can help you multiply every dollar invested as much as three, four, maybe even ten times!
The TFN Complete Guide to Stem Cell Companies Part 4: Share prices below $1
Published on November 24, 2008
Baltimore — (TFN): This is a Part 4 of The TFN Complete Guide to Stem Cell Companies.
Read The TFN Complete Guide to Stem Cell Companies Part 1: Share prices above $50
Read The TFN Complete Guide to Stem Cell Companies Part 2: Share prices between $10 and $50
Read The TFN Complete Guide to Stem Cell Companies [...]
The TFN Complete Guide to Stem Cell Companies Part 3: Share prices between $1 and $10
Published on November 24, 2008
Baltimore — (TFN): This is a Part 3 of The TFN Complete Guide to Stem Cell Companies.
Read The TFN Complete Guide to Stem Cell Companies Part 1: Share prices above $50
Read The TFN Complete Guide to Stem Cell Companies Part 2: Share prices between $10 and $50
Read The TFN Complete Guide to Stem Cell Companies [...]
The TFN Complete Guide to Stem Cell Companies Part 2: Share prices between $10 and $50
Published on November 21, 2008
Baltimore — (TFN): This is a Part 2 of The TFN Complete Guide to Stem Cell Companies.
Read The TFN Complete Guide to Stem Cell Companies Part 1: Share prices above $50
Read The TFN Complete Guide to Stem Cell Companies Part 3: Share prices between $1 and $10
Read The TFN Complete Guide to Stem Cell Companies [...]
The TFN Complete Guide to Stem Cell Companies Part 1: Share prices above $50
Published on November 20, 2008
TFN has compiled an almost complete list of publicly traded stem cell companies that will help you narrow down the field for candidates who may profit for the initial investment surge…
New administration could mean advances — and profits — for U.S. stem cell biotech companies
Published on November 5, 2008
On November 4, Americans will elect liberal super majorities to absolute control of White House and Congress. Within a year, the Judicative, too, will have been reshaped based on redistributionist dogma. Press and academia are already under their control. And recent “bailouts” have entrenched government deep in the heart of key industries. We’re entering the most dangerous period in American history…
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down